1. [P3–044]: FUNCTIONAL AND PHARMACOLOGICAL CHARACTERIZATION OF A NOVEL AND SELECTIVE MUSCARINIC ACETYLCHOLINE M4 RECEPTOR ACTIVATOR. (1st July 2017) Authors: Popiolek, Michael; Tierney, Patrick L.; Young, Damon; Lotarski, Susan; Kozak, Rouba Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 19 Page Start: P946 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of M1 and M4 activation on excitatory synaptic transmission in CA1. Issue 7 (5th May 2017) Authors: Thorn, Catherine A.; Popiolek, Michael; Stark, Eda; Edgerton, Jeremy R. Journal: Hippocampus Issue: Volume 27:Issue 7(2017) Page Start: 794 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Meta‐analysis of amantadine efficacy for improving preclinical research reliability. Issue 10 (4th October 2018) Authors: Stanley, Philip; Pioli, Elsa Y.; Kozak, Rouba; Popiolek, Michael; Bezard, Erwan Journal: Movement disorders Issue: Volume 33:Issue 10(2018) Page Start: 1555 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Oral administration of D-alanine in monkeys robustly increases plasma and cerebrospinal fluid levels but experimental D-amino acid oxidase inhibitors had minimal effect. (September 2016) Authors: Rojas, Camilo; Alt, Jesse; Ator, Nancy A; Wilmoth, Heather; Rais, Rana; Hin, Niyada; DeVivo, Michael; Popiolek, Michael; Tsukamoto, Takashi; Slusher, Barbara S Journal: Journal of psychopharmacology Issue: Volume 30:Number 9(2016:Sep.) Page Start: 887 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗